ALZHEIMER'S DISEASE NEEDS EARLY DIAGNOSIS

12 June 1994

Until recently, "we have not been able to distinguish between normal mental aging and the early symptoms of a disease condition," Willem van Tilberg, president of the International Psychogeriatric Association meeting, held in Amsterdam, the Netherlands, last week, told delegates. But now, he added, with better diagnostic techniques available, "we may be able to detect Alzheimer's disease earlier and begin treatment when it is most effective - when symptoms are still mild."

Prof van Tilberg pointed out that the brain has a large excess capacity, which helps it to compensate for the deterioration of neurones. Symptoms of dementia only develop as these compensatory mechanisms become saturated, and for pharmacologic treatment to give the best results, he said, it must be started while as much residual capacity remains as possible.

Improving memory itself is still an unrealistic goal even in normal people, said Betto Deelan of the University Hospital in Groningen, the Netherlands, "so at this stage we should focus on improving memory performance on specific, relevant tasks."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight